More Shareholders Sue Medtronic Over Infuse Claims

Medtronic found itself at the center of another shareholder lawsuit accusing it of artificially boosting its stock price and forcing the company to repurchase more than $2.8 billion of its own shares at inflated rates.
Mass Device